Jade Biosciences, Inc. — All Filings
461 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS EX
RW
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001172661-25-002448 | Jun 20, 2025 | — |
| SCHEDULE 13G | — | 0000315066-25-001642 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-074496 | May 19, 2025 | May 16, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-072763 | May 15, 2025 | — |
| 8-K | 8-K | 0001193125-25-119856 | May 14, 2025 | — |
| 144 | — | 0001961863-25-000055 | May 6, 2025 | — |
| 144 | — | 0001961863-25-000056 | May 6, 2025 | — |
| SCHEDULE 13G | — | 0001415889-25-011957 | May 5, 2025 | — |
| SCHEDULE 13G | — | 0001415889-25-011894 | May 5, 2025 | — |
| 4 | 4 | 0000950170-25-062091 | May 1, 2025 | Apr 29, 2025 |
| 4 | 4 | 0000950170-25-062102 | May 1, 2025 | Apr 29, 2025 |
| 4 | 4 | 0000950170-25-062107 | May 1, 2025 | Apr 29, 2025 |
| 4 | 4 | 0000950170-25-062119 | May 1, 2025 | Apr 29, 2025 |
| 4 | 4 | 0000950170-25-062123 | May 1, 2025 | Apr 29, 2025 |
| SCHEDULE 13D | — | 0000950170-25-062146 | May 1, 2025 | — |
| 3 | 3 | 0000950170-25-062077 | May 1, 2025 | Apr 28, 2025 |
| 8-K | 8-K | 0001193125-25-110004 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062018 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062020 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062026 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062032 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062039 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062056 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062059 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062065 | May 1, 2025 | Apr 28, 2025 |
| 3 | 3 | 0000950170-25-062086 | May 1, 2025 | Apr 28, 2025 |
| SCHEDULE 13D/A | — | 0001415889-25-011576 | Apr 30, 2025 | — |
| SCHEDULE 13D/A | — | 0001415889-25-011581 | Apr 30, 2025 | — |
| 4 | — | 0001415889-25-011583 | Apr 30, 2025 | Apr 28, 2025 |
| 8-K | 8-K | 0001193125-25-103761 | Apr 29, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-005564 | Apr 25, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001558370-25-005278 | Apr 23, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-036566 | Apr 21, 2025 | Apr 16, 2025 |
| 425 | 425 | 0001104659-25-033398 | Apr 9, 2025 | — |
| 425 | 425 | 0001104659-25-033410 | Apr 9, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-033200 | Apr 9, 2025 | — |
| 425 | 425 | 0001104659-25-033201 | Apr 9, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-033397 | Apr 9, 2025 | — |
| 425 | 425 | 0001104659-25-032441 | Apr 7, 2025 | — |
| 425 | 425 | 0001558370-25-004513 | Apr 7, 2025 | — |
| 8-K | 8-K | 0001558370-25-004511 | Apr 7, 2025 | — |
| 10-K | 10-K | 0001558370-25-003750 | Mar 27, 2025 | Dec 31, 2024 |
| 425 | 425 | 0001104659-25-028277 | Mar 26, 2025 | — |
| SEC STAFF LETTER | — | 9999999997-25-001554 | Mar 25, 2025 | — |
| 424B3 | 424B3 | 0001104659-25-027785 | Mar 25, 2025 | — |
| ARS | ARS | 0001104659-25-027820 | Mar 25, 2025 | Dec 31, 2024 |
| EFFECT | — | 9999999995-25-000770 | Mar 25, 2025 | — |
| S-4/A | S-4/A | 0001104659-25-026998 | Mar 24, 2025 | — |
| CORRESP | — | 0001104659-25-027001 | Mar 24, 2025 | — |
| CORRESP | — | 0001104659-25-027004 | Mar 24, 2025 | — |